QT Interval Prolongation: Preclinical and Clinical Testing Arrhythmogenesis in Drugs and Regulatory Implications

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|5|1|54-57

ISSN： 1574-8863

Source： Current Drug Safety, Vol.5, Iss.1, 2010-01, pp. : 54-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation

By  

Current Drug Safety, Vol. 5, Iss. 1, 2010-01 ,pp. : 105-111

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot topic: Drug-Induced QT Interval Prolongation: Clinical, Safety and Regulatory Update (Guest Editor: Guillermo Di Girolamo)]

By  

Current Drug Safety, Vol. 5, Iss. 1, 2010-01 ,pp. : 41-43

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Drug Induced QT Interval Prolongation

By  

Current Drug Safety, Vol. 5, Iss. 1, 2010-01 ,pp. : 44-53

Bentham Science Publishers

Access to resources Recommend Favorite

Antimicrobial Agents-Associated with QT Interval Prolongation

By  

Current Drug Safety, Vol. 5, Iss. 1, 2010-01 ,pp. : 85-92

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Drugs Inducing QT Prolongation: Facts and Evidence

By  

Current Drug Safety, Vol. 5, Iss. 1, 2010-01 ,pp. : 65-72

Bentham Science Publishers

Access to resources Recommend Favorite